Skip to content

Neuromuscular Electrical Stimulation Following Total Hip Arthroplasty

Haemodynamic Performance of Neuromuscular Electrical Stimulation (NMES) During Recovery From Total Hip Arthroplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01785251
Enrollment
11
Registered
2013-02-07
Start date
2011-06-30
Completion date
2012-02-29
Last updated
2013-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Vein Thrombosis, Total Hip Arthroplasty

Keywords

Neuromuscular electrical stimulation, NMES, Deep vein thrombosis, DVT, total hip arthroplasty, lower limb hemodynamics

Brief summary

Patients post total hip arthroplasty (THA) remain at high risk of developing Deep Vein Thrombosis (DVT) during the recovery period following surgery despite the availability of effective pharmacological and mechanical prophylactic methods. The use of calf muscle neuromuscular electrical stimulation (NMES) during the hospitalised recovery period on this patient group may be effective at preventing DVT. However, the haemodynamic effectiveness and comfort characteristics of NMES in post-THA patients immediately following surgery have yet to be established. The main objectives are: 1. To establish if patients in the early post-operative period have tolerance for NMES. 2. To determine if applying NMES to patients immediately post-THA increases venous outflow from the lower limb over resting conditions.

Interventions

DEVICENeuromuscular Electrical Stimulation

Applied using a custom built, medically approved stimulator called the Duo-STIM. NMES to be applied to the calf muscles to elicit a muscular contraction to eject blood through the venous system.

Sponsors

Irish Research Council
CollaboratorOTHER
Mid Western Regional Hospital, Ireland
CollaboratorOTHER
National University of Ireland, Galway, Ireland
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients who underwent total hip arthroplasty the previous day

Exclusion criteria

* Patients with Diabetes Mellitus * Patients with Peripheral Vascular Disease * Patients currently involved in another trial * Previous diagnosis of DVT

Design outcomes

Primary

MeasureTime frameDescription
Lower limb haemodynamic performance4 hoursDuplex Doppler ultrasound will be used as the outcome measure. Both legs will be measured for hemodynamic performance in the popliteal vein by placing the probe at the popliteal fossa. Measurements of peak venous velocity (cm/s), popliteal vein diameter (cm), time averaged mean velocity (TAMEAN, cm/s) and volume flow (ml/min) will be recorded. Doppler measurements will be taken initially at rest, before the application of NMES and once again when the NMES session had commenced.

Secondary

MeasureTime frameDescription
Patient comfort during application of NMES4 hoursMeasurements will be taken at 3 time points (before application of NMES, after application of NMES had begun and at the end of the protocol). The measurement consists of asking patients to mark their level of comfort using a 100mm, non-hatched visual-analogue-scale (VAS). A VAS of 30 mm or less will be categorised as mild pain, between 31 and 69mm as moderate pain and scores of 70mm or greater as severe pain.

Countries

Ireland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026